UK markets open in 7 hours 51 minutes
  • NIKKEI 225

    28,964.08
    -54.22 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.67 (+0.85%)
     
  • CRUDE OIL

    71.89
    +0.25 (+0.35%)
     
  • GOLD FUTURES

    1,768.80
    -0.20 (-0.01%)
     
  • DOW

    33,290.08
    -533.32 (-1.58%)
     
  • BTC-GBP

    25,748.92
    -141.80 (-0.55%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • ^IXIC

    14,030.38
    -131.02 (-0.93%)
     
  • ^FTAS

    4,002.07
    -69.26 (-1.70%)
     

Global Multiple Sclerosis Epidemiology and Patient Flow Forecast to 2035 - ResearchAndMarkets.com

·2-min read

The "Global Multiple Sclerosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2021, provides Multiple Sclerosis epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Multiple Sclerosis patients, history of the disease at the population level (Multiple Sclerosis prevalence, Multiple Sclerosis incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Multiple Sclerosis patient flow: Multiple Sclerosis prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Multiple Sclerosis patients by age group, gender

  • Forecast: Multiple Sclerosis epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Multiple Sclerosis market sizing, assessing market potential, and developing drug forecast models

  • Identify Multiple Sclerosis patients segments through age groups, gender, and disease sub-types

  • Develop Multiple Sclerosis population-based health management frameworks

  • Evaluate Multiple Sclerosis market opportunities, identify target patient population

  • Align marketing decisions with the Multiple Sclerosis target population

  • Communicate leadership and health authorities about your Multiple Sclerosis target patient population

Key Topics Covered:

1. Research Methodology

2. Multiple Sclerosis Patients Definition

3. US Multiple Sclerosis Epidemiology and Patient Flow

4. Germany Multiple Sclerosis Epidemiology and Patient Flow

5. France Multiple Sclerosis Epidemiology and Patient Flow

6. Italy Multiple Sclerosis Epidemiology and Patient Flow

7. Spain Multiple Sclerosis Epidemiology and Patient Flow

8. UK Multiple Sclerosis Epidemiology and Patient Flow

9. Europe Multiple Sclerosis Epidemiology and Patient Flow

10. Japan Multiple Sclerosis Epidemiology and Patient Flow

11. Global Multiple Sclerosis Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/8zelx3

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005560/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting